WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Stock Short Interest Falls 71.0%

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) was the target of a large drop in short interest during the month of October. As of October 15th, there was short interest totaling 11,170 shares, a drop of 71.0% from the September 30th total of 38,536 shares. Based on an average trading volume of 63,773 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.0% of the company’s shares are sold short.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded WuXi Biologics (Cayman) to a “hold” rating in a research report on Friday, August 28th. One investment analyst has rated the stock with a Hold rating. According to MarketBeat, the company presently has an average rating of “Hold”.

WuXi Biologics (Cayman) Stock Up 1.7%

Shares of OTCMKTS:WXXWY opened at $11.73 on Thursday. The company has a 50-day moving average price of $12.92 and a 200-day moving average price of $10.19. WuXi Biologics has a 12 month low of $7.30 and a 12 month high of $14.80.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company works with pharmaceutical and biotechnology companies to support the discovery, development and commercial manufacturing of therapies, helping customers advance drug candidates from early research through clinical and commercial production.

Its capabilities include antibody and recombinant protein development, cell-line development, process development, clinical trial material production and large-scale biomanufacturing.